Tag Archives: EU

European Pharma 1981-2011: Survival of the Fittest?

By Guest Blogger | Published: October 5, 2011
This month sees Pharmaceutical Executive magazine reach its 30th birthday. In line with that milestone, Reflector assesses what the last three decades have meant for European pharma — and shows how the game has changed beyond recognition. Thirty years is a long time in any industry. The coalmining industry, the market for air travel, or telecommunications [...]
Posted in Emerging Markets, Europe, Global, Guest Blog, IP, Pharm Exec Magazine, R&D, Regulatory, healthcare, leadership | Also tagged , , , , , | Leave a comment

Roche Gets Tough on Greece

By Julian Upton | Published: September 21, 2011
Roche Gets Tough on Greece, Other Eurozone Countries May Follow On Friday Roche confirmed it had come to the end of its tether with state-funded hospitals in Greece. In an interview with the Wall Street Journal, CEO Severin Schwan announced that the company has increased shipments of drugs to pharmacies in the country, while cutting off [...]
Posted in Global, healthcare | Also tagged , , , , | Leave a comment

Europe Wrestles with Outdated Clinical Research Rules

By Guest Blogger | Published: August 31, 2011
By Reflector, Brussels correspondent. Man can live as a free being only when he is free to develop his innate abilities, maintained Baruch Spinoza, that quintessential European, back in the 17th century. He might have been talking about the aspirations in the European pharmaceutical sector, which is currently struggling to articulate a clear plan for escaping [...]
Posted in Europe, Global, Guest Blog, R&D, Regulatory | Also tagged , , | 1 Comment

FDA Finding Fuels Indian Crackdown on Sub-standard Drugs

By Guest Blogger | Published: July 27, 2011
By Mangesh Sai, Asia Correspondent. A routine monthly inspection carried out by the Food and Drugs Administration (FDA) authorities in the state of Maharashtra, India, last month noted an increase in the number of sub-standard drug samples raising apprehensions about the availability of safe and genuine drugs in the state. Officials pointed out that 26 drug samples [...]
Posted in Anti-counterfeiting, Global, Guest Blog, IP, Safety | Also tagged , , , | Leave a comment

Europe: Into the HTA Fray

By Guest Blogger | Published: July 27, 2011
Reflector finds some surprising common ground in what should be two very different HTA reports. Just like with buses, you wait for ages for an international review of health technology assessment to come along, then two turn up at once.
Posted in Europe, Global, Guest Blog, Regulatory, healthcare, pricing | Also tagged , , , , | Leave a comment